查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1478704

脂質奈米顆粒原料市場、佔有率、規模、趨勢、產業分析報告：依產品、適應症、應用、最終用途、地區、細分市場預測，2024-2032 年

Lipid Nanoparticle Raw Materials Market Share, Size, Trends, Industry Analysis Report, By Product (Ionizable lipids, Reagents, Other raw materials); By Disease Indication; By Application; By End-use; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research最新研究顯示，到2032年，全球脂質奈米顆粒原料市場規模預計將達到3.3385億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

對脂質奈米顆粒原料的需求不斷增長，很大程度上是由於對疫苗開發的日益關注。世界人口正在目睹慢性健康問題顯著增加，特別是癌症和血液適應疾病。因此，醫學研究人員面臨著在市場上開發有效的診斷和治療程序的壓力，這將極大地促進對脂質奈米顆粒原料的需求。例如，2023年10月，生物醫學研究所的研究人員宣佈開發出一種用於結腸炎相關癌症的口服液態奈米顆粒藥物。

新研究機構的不斷發展正在對全球脂質奈米顆粒原料市場產生最佳影響。例如，2023年9月，Centre for Process Innovation將在英國引入Center of Excellence RNA，旨在生產用於臨床試驗的脂質奈米顆粒和RNA。此外，從長遠來看，政府增加投資和補貼以促進科學發展可能會進一步促進脂質奈米粒子的生產，特別是解決疫苗不足的問題。例如，2023 年 9 月，Centre of Excellence RNA獲得了 2,600 萬英鎊的資金，以支持開展 RNA 生產和開發活動的公司。

此外，正在進行的產品發佈支持了用於製造疫苗、細胞和基因療法的脂質奈米粒子的開發進展。例如，2024年4月，Cayman Chemicals宣佈推出LipidLaunch研究工具，該工具有潛力發現脂質奈米顆粒。進一步的研究創新可能會揭示脂質奈米顆粒的真正潛力，並在研究期間推動市場成長。例如，《Nature Communication》2024 年發表的一項研究開發了一種使用奈米顆粒的靶向肺載體系統。

此外，研究人員為提高脂質奈米顆粒的生產能力而付出的努力可能會推動脂質奈米顆粒原料市場的成長。例如，2023 年 8 月，研究人員宣佈推出一個新平台，可實現脂質奈米顆粒疫苗（SARS-CoV-2 mRNA）的高生產率。

脂質奈米顆粒原料市場報告亮點

由於其負擔能力和研究活動的靈活性，套件部分預計將出現最高的增長。

由於傳染病引起的健康問題越來越多，傳染病細分市場佔據最大的市場。

由於治療方法開發的進步，預計治療部門將佔收入的更大佔有率。

預計亞太地區將在預測期內實現最快的成長。

目錄

第一章簡介

第二章執行摘要

第三章研究方法論

第四章全球脂質奈米顆粒原料市場洞察

  • 使用情況快照
  • 脂質奈米顆粒原料市場動態
    • 驅動因素和機遇
      • 肺部適應疾病的發生率增加
      • 多種治療配方中更多採用 mRNA 技術
    • 限制因素和課題
      • 複雜的生產過程可能會阻礙市場成長
  • PESTEL 分析
  • 脂質奈米粒原料市場應用趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第五章 全球脂質奈米顆粒原料市場：依適應症分類

  • 主要發現
  • 介紹
  • 癌症
  • 感染
  • 血液適應病
  • 其他

第六章全球脂質奈米顆粒原料市場：副產品

  • 主要發現
  • 介紹
  • 成套工具
  • 試劑
  • 其他

第七章 全球脂質奈米顆粒原料市場：依應用分類

  • 主要發現
  • 介紹
  • 治療
  • 研究

第八章全球脂質奈米顆粒原料市場：依地區

  • 主要發現
  • 介紹
    • 脂質奈米顆粒原料市場評估：依地區，2019-2032
  • 北美
    • 北美：依疾病適應症分類，2019-2032
    • 北美：依申請劃分，2019-2032
    • 北美：依產品分類，2019-2032
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依適應症分類，2019-2032
    • 歐洲：依申請劃分，2019-2032
    • 歐洲：依產品分類，2019-2032
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 亞太地區：依疾病適應症分類，2019-2032
    • 亞太地區：依應用劃分，2019-2032
    • 亞太地區：依產品分類，2019-2032
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印度尼西亞
    • 韓國
  • 中東/非洲
    • 中東和非洲：依疾病分類，2019-2032
    • 中東和非洲：依申請劃分，2019-2032
    • 中東和非洲：依產品分類，2019-2032
    • 沙烏地阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依疾病分類，2019-2032
    • 拉丁美洲：依應用劃分，2019-2032
    • 拉丁美洲：依產品分類，2019-2032
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 競爭格局

  • 擴張和收購分析
    • 擴張
    • 獲得
  • 夥伴關係/協作/協議/揭露

第十章公司簡介

  • Avanti Polar Lipids（美國）
  • .Biopharma PEG Scientific Inc.（美國）
  • BroadPharm（美國）
  • CordenPharma International（德國）
  • Creative Biolabs（美國）
  • Echelon Biosciences（美國）
  • Merck KGaA（德國）
  • NOF AMERICA CORPORATION（美國）
  • Polysciences, Inc.（美國）
  • Tebu Bio（法國）
Product Code: PM4891

The global lipid nanoparticle raw materials market size is expected to reach USD 333.85 million by 2032, according to a new study by Polaris Market Research. The report "Lipid Nanoparticle Raw Materials Market Share, Size, Trends, Industry Analysis Report, By Product (Ionizable lipids, Reagents, Other raw materials); By Disease Indication; By Application; By End-use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising demand for the lipid nanoparticle raw materials is highly attributable to the increasing focus on vaccination development. The worldwide population is witnessing a significant surge in chronic health issues, specifically cancer and blood diseases. This is enforcing healthcare researchers to formulate effective diagnosis and treatment procedures in the marketplace, which will significantly facilitate the need for lipid nanoparticle raw materials. For instance, in October 2023, the researchers at the Institute for Biomedical Science announced the development of an oral liquid nanoparticle drug for colitis-associated cancer.

The increasing development of new research institutes is optimally influencing the global lipid nanoparticle raw material market. For instance, in September 2023, Centre for Process Innovation introduced the Center of Excellence RNA in the UK, aiming to produce lipid nanoparticles and RNA for clinical trials. Additionally, the rising investments and grants by the government to fuel scientific developments, specifically to address the problem of inadequate vaccines, will further fuel the production of lipid nanoparticles in the long run. For instance, in September 2023, the RNA Centre of Excellence received funding of GBP 26 million to assist companies in the production and development activities of RNA.

Furthermore, the ongoing product launches are supporting advancements in the development of lipid nanoparticles for the manufacturing of vaccines, cell and gene therapies. For instance, in April 2024, Cayman Chemicals introduced the LipidLaunch research tools that have the potential to discover lipid nanoparticles. The growing research innovations unravel the true potential of the lipid nanoparticles, which will likely drive market growth during the study period. For instance, a 2024 study published in Nature Communication developed the targeted lung carrier system with the use of nanoparticles.

Additionally, the rising efforts taken by the researchers to increase the production capacity of lipid nanoparticles are likely to drive the growth of the lipid nanoparticle raw material market. For instance, in August 2023, researchers unveiled the launch of a new platform that enables a higher rate of production of lipid nanoparticle vaccines (SARS-CoV-2 mRNA).

Lipid Nanoparticle Raw Materials Market Report Highlights

Kits segment is anticipated to witness the highest growth due to its affordability and flexibility in research activities.

Infectious disease segment accounted for the largest market share owing to the increasing number of health issues due to infections.

Therapeutics segment is projected to experience a larger revenue share due to the growing development of therapies.

APAC is projected to register the fastest growth during the forecast period, attributable to the increasing blood cancer rate in the region.

The global players include Avanti Polar Lipids, Biopharma PEG Scientific Inc., BroadPharm, CordenPharma International, Creative Biolabs, & Echelon Biosciences.

Polaris Market Research has segmented the lipid nanoparticle raw materials market report based on product, disease indication, application, end-use, and region:

Lipid Nanoparticle Raw Materials, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Ionizable lipids
  • PEGylated lipids
  • Sterol lipids
  • Neutral phospholipids
  • Kits
  • Reagents
  • Other raw materials

Lipid Nanoparticle Raw Materials, Disease Indication Outlook (Revenue - USD Million, 2019 - 2032)

  • Cancer
  • Infectious Diseases
  • Blood Diseases
  • Others

Lipid Nanoparticle Raw Materials, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Therapeutics
  • Research

Lipid Nanoparticle Raw Materials, End-use Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

Lipid Nanoparticle Raw Materials, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Lipid Nanoparticle Raw Materials Market Insights

  • 4.1. Lipid Nanoparticle Raw Materials Market - Application Snapshot
  • 4.2. Lipid Nanoparticle Raw Materials Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of lung diseases
      • 4.2.1.2. Increasing adoption of mRNA technology in multiple therapeutic formulations
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complex production process is likely to impede market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Lipid Nanoparticle Raw Materials Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Lipid Nanoparticle Raw Materials Market, by Disease Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • 5.3. Cancer
    • 5.3.1. Global Lipid Nanoparticle Raw Materials Market, by Cancer, by Region, 2019-2032 (USD Million)
  • 5.4. Infectious Diseases
    • 5.4.1. Global Lipid Nanoparticle Raw Materials Market, by Infectious Diseases, by Region, 2019-2032 (USD Million)
  • 5.5. Blood Diseases
    • 5.5.1. Global Lipid Nanoparticle Raw Materials Market, by Blood Diseases, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Lipid Nanoparticle Raw Materials Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Lipid Nanoparticle Raw Materials Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 6.3. Ionizable lipids
    • 6.3.1. Global Lipid Nanoparticle Raw Materials Market, by Ionizable lipids, by Region, 2019-2032 (USD Million)
  • 6.4. Reagents
    • 6.4.1. Global Lipid Nanoparticle Raw Materials Market, by Reagents, by Region, 2019-2032 (USD Million)
  • 6.5. Other raw materials
    • 6.5.1. Global Lipid Nanoparticle Raw Materials Market, by Other raw materials, by Region, 2019-2032 (USD Million)

7. Global Lipid Nanoparticle Raw Materials Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • 7.3. Therapeutics
    • 7.3.1. Global Lipid Nanoparticle Raw Materials Market, by Therapeutics, By Region, 2019-2032 (USD Million)
  • 7.4. Research
    • 7.4.1. Global Lipid Nanoparticle Raw Materials Market, by Research, By Region, 2019-2032 (USD Million)

8. Global Lipid Nanoparticle Raw Materials Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Lipid Nanoparticle Raw Materials Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Lipid Nanoparticle Raw Materials Market - North America
    • 8.3.1. North America: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.3.2. North America: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.3.3. North America: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.3.4. Lipid Nanoparticle Raw Materials Market - U.S.
      • 8.3.4.1. U.S.: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.3.5. Lipid Nanoparticle Raw Materials Market - Canada
      • 8.3.5.1. Canada: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 8.4. Lipid Nanoparticle Raw Materials Market - Europe
    • 8.4.1. Europe: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.4.3. Europe: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.4. Lipid Nanoparticle Raw Materials Market - UK
      • 8.4.4.1. UK: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.4.3. UK: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.5. Lipid Nanoparticle Raw Materials Market - France
      • 8.4.5.1. France: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.5.3. France: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.6. Lipid Nanoparticle Raw Materials Market - Germany
      • 8.4.6.1. Germany: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.7. Lipid Nanoparticle Raw Materials Market - Italy
      • 8.4.7.1. Italy: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.8. Lipid Nanoparticle Raw Materials Market - Spain
      • 8.4.8.1. Spain: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.9. Lipid Nanoparticle Raw Materials Market - Netherlands
      • 8.4.9.1. Netherlands: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.10. Lipid Nanoparticle Raw Materials Market - Russia
      • 8.4.10.1. Russia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 8.5. Lipid Nanoparticle Raw Materials Market - Asia Pacific
    • 8.5.1. Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.4. Lipid Nanoparticle Raw Materials Market - China
      • 8.5.4.1. China: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.4.3. China: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.5. Lipid Nanoparticle Raw Materials Market - India
      • 8.5.5.1. India: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.5.3. India: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.6. Lipid Nanoparticle Raw Materials Market - Malaysia
      • 8.5.6.1. Malaysia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.7. Lipid Nanoparticle Raw Materials Market - Japan
      • 8.5.7.1. Japan: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.8. Lipid Nanoparticle Raw Materials Market - Indonesia
      • 8.5.8.1. Indonesia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.9. Lipid Nanoparticle Raw Materials Market - South Korea
      • 8.5.9.1. South Korea: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 8.6. Lipid Nanoparticle Raw Materials Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.6.4. Lipid Nanoparticle Raw Materials Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.6.5. Lipid Nanoparticle Raw Materials Market - UAE
      • 8.6.5.1. UAE: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.6.6. Lipid Nanoparticle Raw Materials Market - Israel
      • 8.6.6.1. Israel: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.6.7. Lipid Nanoparticle Raw Materials Market - South Africa
      • 8.6.7.1. South Africa: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 8.7. Lipid Nanoparticle Raw Materials Market - Latin America
    • 8.7.1. Latin America: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.7.3. Latin America: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.7.4. Lipid Nanoparticle Raw Materials Market - Mexico
      • 8.7.4.1. Mexico: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.7.5. Lipid Nanoparticle Raw Materials Market - Brazil
      • 8.7.5.1. Brazil: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.7.6. Lipid Nanoparticle Raw Materials Market - Argentina
      • 8.7.6.1. Argentina: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Avanti Polar Lipids (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. .Biopharma PEG Scientific Inc. (US)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BroadPharm (US)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. CordenPharma International (Germany)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Creative Biolabs (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Echelon Biosciences (US)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Merck KGaA (Germany)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. NOF AMERICA CORPORATION (US)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Polysciences, Inc. (US)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Tebu Bio (France)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 2 Global Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 3 Global Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 4 Lipid Nanoparticle Raw Materials Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 6 North America: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 7 North America: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 8 U.S.: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 9 U.S.: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 10 U.S.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 11 Canada: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 12 Canada: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 13 Canada: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 14 Europe: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 15 Europe: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 16 Europe: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 17 UK: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 18 UK: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 19 UK: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 20 France: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 21 France: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 22 France: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 23 Germany: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 24 Germany: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 25 Germany: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 26 Italy: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 27 Italy: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 28 Italy: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 29 Spain: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 30 Spain: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 31 Spain: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 32 Netherlands: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 33 Netherlands: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 34 Netherlands: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 35 Russia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 36 Russia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 37 Russia: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 41 China: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 42 China: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 43 China: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 44 India: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 45 India: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 46 India: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 47 Malaysia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 48 Malaysia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 49 Malaysia: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 50 Japan: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 51 Japan: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 52 Japan: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 53 Indonesia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 54 Indonesia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 55 Indonesia: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 56 South Korea: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 57 South Korea: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 58 South Korea: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 65 UAE: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 66 UAE: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 67 UAE: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 68 Israel: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 69 Israel: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 70 Israel: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 71 South Africa: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 72 South Africa: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 73 South Africa: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 74 Latin America: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 75 Latin America: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 76 Latin America: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 77 Mexico: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 78 Mexico: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 79 Mexico: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 80 Brazil: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 81 Brazil: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 82 Brazil: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 83 Argentina: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 84 Argentina: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 85 Argentina: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Lipid Nanoparticle Raw Materials Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Lipid Nanoparticle Raw Materials Market, by Product, 2022 & 2032 (USD Million)
  • Figure 8. Market by Disease Indication
  • Figure 9. Global Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2022 & 2032 (USD Million)
  • Figure 10. Market by Application
  • Figure 11. Global Lipid Nanoparticle Raw Materials Market, by Application , 2022 & 2032 (USD Million)
  • Figure 12. Lipid Nanoparticle Raw Materials Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Lipid Nanoparticle Raw Materials Market